Evidence map›Paper›PMID 41552260›Full record

ArticleCureus2025

Duplicate Submission, Zero Consequences: A Reviewer's First-Person Case Study.

Enzo Emanuele

Abstract readEditorial
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Enzo EmanuelePathology, 2E Science, Robbio, ITA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although submitting identical or substantially overlapping manuscripts to multiple journals constitutes research misconduct, current detection mechanisms rely mostly on chance. This creates a risk-reward landscape in which unethical authors may face minimal consequences even when duplicate submissions are identified, while gaining a considerable advantage when they are not. This case study presents the firsthand discovery of a duplicate submission during peer review and describes major shortcomings in the subsequent editorial handling. On April 28, 2025, while reviewing a manuscript on occupational radiation exposure for an academic journal, a routine literature search showed that a nearly identical article had been published earlier that month in another open-access journal. Despite prompt notification from the editorial office, the journal continued with standard peer review, obtaining four full referee reports before rejecting the submission on May 28, 2025. The decision letter made no mention of an ethics investigation, institutional notification, or any corrective action. The authors appear to have faced no meaningful sanctions, having already published the article in another journal while the same manuscript remained under review elsewhere. This case illustrates how unethical authors can submit the same work to multiple journals simultaneously, wait for the fastest or most favorable review, and abandon other submissions without penalty. At worst, they receive a routine rejection without ethical consequences. These observations suggest that penalties for detected duplicate submissions are minimal, whereas the potential benefits of undetected misconduct remain high. To correct this incentive imbalance, future digital infrastructure initiatives in scholarly publishing should establish robust pre-submission and pre-review screening protocols, standardized investigation procedures for suspected violations, and enforceable sanctions, including institutional notification, time-limited submission bans, and, most importantly, the retraction of published articles found to have been the subject of duplicate submission.

Indexed as

academic publishingduplicate submissionpeer review integritypublication ethicsresearch misconductrisk-reward asymmetrysimultaneous submission

Identifiers

PMID41552260
PMCPMC12811804

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.